Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neurobiology of Aging

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2011.02.015PMID 21482444PMCID PMC3135676
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microglia in neurodegenerative disease

  2010cited by this paper
• Composite Primary Neuronal High-Content Screening Assay for Huntington’s Disease Incorporating Non-Cell-Autonomous Interactions

  2010influential reference
• CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease.

  2010influential reference
• Crosstalk pathways between Toll-like receptors and the complement system.

  2010cited by this paper
• C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production

  2010cited by this paper
• Altered P2X7‐receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration

  2009cited by this paper
• The influence of microglia on the pathogenesis of Parkinson's disease.

  2009cited by this paper
• Resting Microglia Directly Monitor the Functional State of Synapses In Vivo and Determine the Fate of Ischemic Terminals

  2009cited by this paper
• Microglial clearance function in health and disease.

  2009cited by this paper
• Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival.

  2009cited by this paper
• Debris clearance by microglia: an essential link between degeneration and regeneration

  2008cited by this paper
• A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

  2008cited by this paper
• Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease.

  2008cited by this paper
• Dysregulation of Gene Expression in Primary Neuron Models of Huntington's Disease Shows That Polyglutamine-Related Effects on the Striatal Transcriptome May Not Be Dependent on Brain Circuitry

  2008cited by this paper
• Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment*

  2008cited by this paper
• Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates.

  2007cited by this paper
• Huntington's disease

  2007cited by this paper
• Evidence for synaptic stripping by cortical microglia

  2007cited by this paper
• Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease

  2007cited by this paper
• Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus

  2007cited by this paper
• The classical complement cascade mediates CNS synapse elimination.

  2007influential reference
• Microglia: active sensor and versatile effector cells in the normal and pathologic brain

  2007cited by this paper
• The corticostriatal pathway in Huntington's disease.

  2007cited by this paper
• Imaging microglial activation in Huntington's disease.

  2007influential reference
• Microglial activation correlates with severity in Huntington disease

  2006cited by this paper
• Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity

  2005cited by this paper
• Synaptic dysfunction in Huntington’s disease: a new perspective

  2005cited by this paper
• Normal huntingtin function: an alternative approach to Huntington's disease

  2005cited by this paper
• Microglia in health and disease

  2005cited by this paper
• A refined in vitro model to study inflammatory responses in organotypic membrane culture of postnatal rat hippocampal slices

  2005cited by this paper
• Early changes in Huntington’s disease patient brains involve alterations in cytoskeletal and synaptic elements

  2004cited by this paper
• Nuclear Factor E2-Related Factor 2-Dependent Antioxidant Response Element Activation by tert-Butylhydroquinone and Sulforaphane Occurring Preferentially in Astrocytes Conditions Neurons against Oxidative Insult

  2004cited by this paper
• CXCR3-Dependent Microglial Recruitment Is Essential for Dendrite Loss after Brain Lesion

  2004cited by this paper
• Huntingtin and the molecular pathogenesis of Huntington's disease

  2004cited by this paper
• Displacement of synaptic terminals from regenerating motoneurons by microglial cells

  2004cited by this paper
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

  2004cited by this paper
• Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats.

  2004cited by this paper
• Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro

  2004cited by this paper
• Neuronal injury mediated via stimulation of microglial toll‐like receptor‐9 (TLR9)

  2004cited by this paper
• Huntington's disease: a synaptopathy?

  2003cited by this paper
• Modification of microglia function protects from lesion‐induced neuronal alterations and promotes sprouting in the hippocampus

  2003cited by this paper
• Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease

  2003cited by this paper
• Microglia density decreases with age in a mouse model of Huntington's disease

  2003cited by this paper
• Microglial activation and recruitment, but not proliferation, suffice to mediate neurodegeneration

  2002cited by this paper
• Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.

  2002cited by this paper
• Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells.

  2002cited by this paper
• Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

  2002influential reference
• Microglial activation by purines and pyrimidines

  2002cited by this paper
• Enhanced glial activation and expression of specific CNS inflammation-related molecules in aged versus young rats following cortical stab injury.

  2001cited by this paper
• Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001influential reference
• Microglial Phagocytosis of Apoptotic Inflammatory T Cells Leads to Down-Regulation of Microglial Immune Activation1

  2001cited by this paper
• Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity

  2001cited by this paper
• C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and Cd91 Initiates Macropinocytosis and Uptake of Apoptotic Cells

  2001cited by this paper
• Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice

  2001influential reference
• Huntington aggregates may not predict neuronal death in Huntington's disease.

  1999cited by this paper
• Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology

  1999influential reference
• Huntingtin aggregates may not predict neuronal death in Huntington's disease

  1999cited by this paper
• Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease.

  1999cited by this paper
• Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

  1999influential reference
• Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice.

  1999cited by this paper
• Biochemical abnormalities and excitotoxicity in Huntington's disease brain

  1999cited by this paper
• Temporal Profile and Cellular Localization of Interleukin-6 Protein after Focal Cerebral Ischemia in Rats

  1999cited by this paper
• Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.

  1999cited by this paper
• Nature of the Retrograde Signal from Injured Nerves that Induces Interleukin-6 mRNA in Neurons

  1999cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

  1998cited by this paper
• Vitamin E induces ramification and downregulation of adhesion molecules in cultured microglial cells

  1998cited by this paper
• The microglia/macrophage response in the neonatal rat facial nucleus following axotomy.

  1998cited by this paper
• Ramification of microglia, monocytes and macrophages in vitro: influences of various epithelial and mesenchymal cells and their conditioned media*

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997cited by this paper
• Neuron-microglia interactions in vitro

  1996cited by this paper
• Activation of microglial cells by beta-amyloid protein and interferon-gamma.

  1995cited by this paper
• Microglia: intrinsic immuneffector cell of the brain.

  1995cited by this paper
• Excitotoxic degeneration is initiated at non-random sites in cultured rat cerebellar neurons

  1995cited by this paper
• Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies.

  1995cited by this paper
• Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form

  1995cited by this paper
• Neuronal transfection in brain slices using particle-mediated gene transfer.

  1994influential reference
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Amoeboid Microglial Cells and not Astrocytes Synthesize TNF-alpha in Swiss Mouse Brain Cell Cultures.

  1990cited by this paper
• Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease.

  1990cited by this paper
• Amoeboid Microglial Cells and not Astrocytes Synthesize TNF‐α in Swiss Mouse Brain Cell Cultures

  1990cited by this paper
• Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy.

  1988cited by this paper
• Huntington's disease. Pathogenesis and management.

  1986cited by this paper
• Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease.

  1985cited by this paper
• Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

  1980cited by this paper

• Antioxidant and Anti-Inflammatory Defenses in Huntington’s Disease: Roles of NRF2 and PGC-1α, and Therapeutic Strategies

  2025cites this paper
• Emerging roles of microglia and neuroinflammation in Huntington's disease: From pathophysiology to clinical trials

  2025cites this paper
• Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease.

  2025cites this paper
• Advances in Stem Cell Therapy for Huntington’s Disease: A Comprehensive Literature Review

  2025cites this paper
• Neuroprotective Effects of Glucosamine in Huntington’s Disease Through NLRP3 Inflammasome Inhibition

  2025cites this paper
• TYROBP/DAP12 knockout in Huntington’s disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration

  2024cites this paper
• The Impact of Aging on Neurological Diseases in the Elderly: Molecular Mechanisms and Therapeutic Perspectives

  2024cites this paper
• Protective Effects of Antcin H Isolated from Antrodia cinnamomea Against Neuroinflammation in Huntington’s Disease via NLRP3 Inflammasome Inhibition

  2024cites this paper
• Brain incoming call from glia during neuroinflammation: Roles of extracellular vesicles.

  2024cites this paper
• Dopaminergic system and neurons: Role in multiple neurological diseases.

  2024cites this paper
• In vivo CRISPR base editing for treatment of Huntington’s disease

  2024cites this paper
• Neuroinflammation as a therapeutic target in Huntington’s disease

  2024cites this paper
• Mechanisms of Microglia Proliferation in a Rat Model of Facial Nerve Anatomy

  2023cites this paper
• Interleukin-6 as a marker of Huntington's disease progression: Systematic review and meta-analysis

  2023cites this paper
• Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis.

  2023cites this paper
• Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases

  2023cites this paper
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

  2023cites this paper
• From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research

  2023cites this paper
• Microglial and Astrocytic Responses in the Human Midcingulate Cortex in Huntington's Disease

  2023cites this paper
• Distinct phases of adult microglia proliferation: a Myc-mediated early phase and a Tnfaip3-mediated late phase

  2022cites this paper
• Deletion of the microglial transmembrane immune signaling adaptor TYROBP ameliorates Huntington’s disease mouse phenotype

  2022cites this paper
• Distinct phases of adult microglia proliferation: a Myc-mediated early phase and a Tnfaip3-mediated late phase

  2022cites this paper
• Inflammasome activation and assembly in Huntington's disease.

  2022cites this paper
• Hunting for the cause: Evidence for prion-like mechanisms in Huntington’s disease

  2022cites this paper
• A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington’s disease

  2022cites this paper
• Assessing Microglial Dynamics by Live Imaging

  2021cites this paper
• Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia

  2021cites this paper
• Neuroinflammation in Huntington’s

  2021cites this paper
• Nicotinamide Adenine Dinucleotide Phosphate Oxidases Are Everywhere in Brain Disease, but Not in Huntington’s Disease?

  2021cites this paper
• Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species

  2021cites this paper
• Microglia regulate synaptic development and plasticity

  2021cites this paper
• An interplay between immune response and neurodegenerative disease progression: An assessment using Drosophila as a model.

  2020cites this paper
• Microglial Innate Memory and Epigenetic Reprogramming in Neurological Disorders.

  2020cites this paper
• cGAS, a DNA Sensor, Promotes Inflammatory Responses in Huntington Disease

  2020cites this paper
• Neuroimmune Connections in Aging and Neurodegenerative Diseases.

  2020cites this paper
• The microbiota–microglia axis in central nervous system disorders

  2020cites this paper
• Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease

  2020cites this paper
• Heat-Shock Proteins in Neuroinflammation

  2019cites this paper
• Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington’s disease

  2019cites this paper
• Mutant huntingtin protein alters the response of microglial cells to inflammatory stimuli

  2019cites this paper
• Microglia-mediated neuroinflammation in neurodegenerative diseases.

  2019cites this paper
• IKKβ slows Huntington’s disease progression in R6/1 mice

  2019cites this paper
• Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease

  2019cites this paper
• Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington’s Disease: Insights from In Vitro and In Vivo Models

  2019cites this paper
• The Role of Microglia and Astrocytes in Huntington’s Disease

  2019cites this paper
• Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease.

  2019cites this paper
• Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington’s disease pathology

  2019cites this paper
• Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases.

  2018cites this paper
• Brain state before a memory probe and associative retrieval in older adults

  2018cites this paper
• Rodent models for Alzheimer disease

  2018cites this paper
• What is the evidence that tau pathology spreads through prion-like propagation?

  2017cites this paper
• Dysregulation of gene expression in the striatum of BACHD rats expressing full‐length mutant huntingtin and associated abnormalities on molecular and protein levels

  2017cites this paper
• Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.

  2017cites this paper
• Investigation into pathological neuronal-myeloid cell interactions and rescue of hyper-reactive immune responses in Huntington's disease

  2017cites this paper
• Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target

  2017cites this paper
• Microglial Activation in the Pathogenesis of Huntington’s Disease

  2017cites this paper
• IKK&bgr; and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD

  2017cites this paper
• Primate retinal cones express phosphorylated tau associated with neuronal degeneration yet survive in old age

  2017cites this paper
• Sodium Channels, Mitochondria, and Axonal Degeneration in Peripheral Neuropathy.

  2016cites this paper
• Trehalose rescues glial cell dysfunction in striatal cultures from HD R6/1 mice at early postnatal development.

  2016cites this paper
• Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis.

  2016cites this paper
• Flow cytometric characterization of microglia in the offspring of PolyI:C treated mice.

  2016cites this paper
• Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell‐type‐specific

  2016cites this paper
• Neuroinflammation bei neurodegenerativen Erkrankungen

  2015cites this paper
• Macrophage populations and self-renewal: Changing the paradigm

  2015cites this paper
• Is membrane homeostasis the missing link between inflammation and neurodegenerative diseases?

  2015cites this paper
• Microglial Dynamics and Role in the Healthy and Diseased Brain

  2015cites this paper
• Role of Microglia Adenosine A2A Receptors in Retinal and Brain Neurodegenerative Diseases

  2014cites this paper
• Neuroinfl ammation in Huntington's Disease

  2014cites this paper
• In Vitro Systems in Neurotoxicological Studies

  2014cites this paper
• Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors

  2014cites this paper
• AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons.

  2014cites this paper
• The influence of cannabinoids on generic traits of neurodegeneration

  2014cites this paper
• Innate immune activation in neurodegenerative disease

  2014cites this paper
• Impulse Conduction Increases Mitochondrial Transport in Adult Mammalian Peripheral Nerves In Vivo

  2013cites this paper
• Tau Oligomers and Fibrils Induce Activation of Microglial Cells

  2013cites this paper
• Spumiform basement membrane aberrations in the microvasculature of the midbrain periaqueductal gray region in hamster: rostro-caudal pathogenesis?

  2013cites this paper
• Taking shape : regulating mitochondria morphology through alternative splicing and phosphorylation of fission factor proteins

  2013cites this paper
• Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders

  2013cites this paper
• Chronic Effects of Cannabinoid Drugs on Monoaminergic Systems and the Role of Endocannabinoids and Cannabinoid Receptors in Human Brain Disorders

  2013cites this paper
• Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia

  2012cites this paper
• Microglia in the developing brain: a potential target with lifetime effects.

  2012cites this paper
• Cannabinoid 2 receptor (CB2R) agonists modulate neuropathic pain and cytokine expression

  2012cites this paper
• Huntington’s Disease and the Striatal Medium Spiny Neuron: Cell-Autonomous and Non-Cell-Autonomous Mechanisms of Disease

  2012cites this paper
• An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity

  2012cites this paper
• Features of Microglia and Neuroinflammation Relevant to Environmental Exposure and Neurotoxicity

  2011cites this paper